Sanofi
$49.799876543210-$,.9876543210-$,.9876543210-$,.9876543210-$,.9876543210-$,.9876543210-$,.9876543210-$,.
$49.79
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
+$0.28 (+0.57%) Today
$0.00 (0.00%) As of 8:00 PM EST after-hours
Why Robinhood?
You can watch Sanofi and buy or sell other stocks, options, ETFs, and crypto commission-free!
About SNY
Sanofi engages in the research, production and distribution of pharmaceutical products. It operates through the following business segments: Pharmaceuticals, Consumer Healthcare, and Human Vaccines. Read More The Pharmaceuticals segment comprises the commercial operations of the following global franchises: specialty care, diabetes & cardiovascular, established prescription products and generics, together with research, development and production activities. This segment also includes all associates whose activities are related to pharmaceuticals. The Consumer Healthcare segment comprises, for all geographical territories, the commercial operations for its Consumer Healthcare products, together with research, development and production activities dedicated to those products. The Vaccines segment comprises, for all geographical territories, the commercial operations of Sanofi Pasteur, together with research, development and production activities dedicated to vaccines. The company was founded in 1973 and is headquartered in Paris, France.
CEO
Employees
104,226
Headquarters
Paris, Ile-de-France
Founded
1973
Market Cap
123.32B
Price-Earnings Ratio
30.02
Dividend Yield
2.32
Average Volume
3.33M
High Today
$49.89
Low Today
$49.48
Open Price
$49.48
Volume
3.14M
52 Week High
$49.89
52 Week Low
$40.00
Collections
SNY News
Washington PostDec 10
Flagging French Drug Giant Tries a Familiar Remedy
All of the moves make some sense and are in line with what other large drugmakers, including his prior employer, have tried in recent years. The key to success
Analyst Ratings
63%
of 24 ratings
Buy
63%
Hold
33%
Sell
4%
SNY Earnings
$0.63
$1.12
$1.61
$2.10
Q1 2018
Q2 2018
Q3 2018
Q4 2018
Q1 2019
Q2 2019
Q3 2019
Q4 2019
Estimated
—
Actual
Available Feb 6, Pre-Market
You May Also Like
More SNY News
MarketWatchDec 10
Sanofi says trial of sutimlimab met main goals
Sanofi SA SNY, -1.59% said a Phase 3 trial of sutimlimab in people with primary cold agglutinin disease met its primary and secondary endpoints. The primary ef
MarketWatchDec 10
Regeneron shares fall as Sanofi signals stake sale
Shares of Regeneron Pharmaceuticals Inc. REGN, +0.54% slipped more than 3% in premarket trading Tuesday after French partner Sanofi SA (SAN.FR) indicated it wouBloombergDec 10
Sanofi’s CEO Quits Diabetes as Cancer Breakthroughs Beckon
(Bloomberg) -- Sanofi’s new chief executive, just three months into the job, is taking a scalpel to traditional areas of research to rejuvenate the sluggish Fre
ReutersDec 10
Sanofi shares rally on new margin goals, narrower drug focus
PARIS (Reuters) - Shares in Sanofi (SASY.PA) rose on Tuesday after the French drugmaker said it would focus on vaccines and treatments like its promising eczema
ReutersDec 10
